LOCALLY ADVANCED SOLID TUMOR
Clinical trials for LOCALLY ADVANCED SOLID TUMOR explained in plain language.
Never miss a new study
Get alerted when new LOCALLY ADVANCED SOLID TUMOR trials appear
Sign up with your email to follow new studies for LOCALLY ADVANCED SOLID TUMOR, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental cell therapy tested in advanced cancer patients
Disease control OngoingThis early-stage study is testing a new cell therapy called PD-L1 t-haNK in adults with advanced solid cancers that have spread or can't be surgically removed. The main goals are to find the safest dose and check for side effects in a small group of 16 participants who have alrea…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1 • Sponsor: ImmunityBio, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:42 UTC
-
New pill targets genetic weakness in advanced cancers
Disease control OngoingThis early-stage study is testing a new oral medication called TNG908 in people with advanced solid tumors that have a specific genetic deletion called MTAP. The research aims to find the safest dose and see if the drug shows any signs of fighting the cancer. Up to 192 participan…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Tango Therapeutics, Inc. • Aim: Disease control
Last updated Mar 31, 2026 12:12 UTC
-
New Long-Acting cancer drug seeks to boost immune system against tumors
Disease control OngoingThis early-stage trial is testing a new long-acting immunotherapy drug called TransCon IL-2 β/γ in adults with advanced solid tumors that have spread or cannot be removed by surgery. The study aims to find safe doses and see if the drug, given alone or with other cancer treatment…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Ascendis Pharma Oncology Division A/S • Aim: Disease control
Last updated Mar 23, 2026 15:17 UTC
-
New hope drug enters human testing for Tough-to-Treat cancers
Disease control OngoingThis is the first study in people testing a new drug called TST003 for patients with advanced solid tumors that have spread or cannot be removed by surgery. The main goals are to find a safe dose, check for side effects, and see if the drug can help shrink tumors, especially in c…
Matched conditions: LOCALLY ADVANCED SOLID TUMOR
Phase: PHASE1, PHASE2 • Sponsor: Suzhou Transcenta Therapeutics Co., Ltd. • Aim: Disease control
Last updated Mar 23, 2026 15:15 UTC